Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2021

Oct 25, 2021

30893_dirs_2021-10-25_81729f55-c985-4ae2-8157-c2d7f3004ccf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2021-10-25

Reporting Person: Ryan Scott P (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-25 Common Stock M 4580.00 $16.01 Acquired 35789.00 Direct
2021-10-25 Common Stock S 9224.00 $34.27 Disposed 26565.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-10-25 Employee Stock Option (Right to Buy) $16.01 M 4580.00 Disposed 2022-12-31 Common Stock (4580.00) Direct

Footnotes

F1: Column 5 reflects the acquisition of 582 shares under the Gentex Corp. Employee Stock Purchase Plan.

F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F3: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.